Kynam Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.9M | Sell |
3,071,588
-128,412
| -4% | -$4.17M | 10.75% | 2 |
|
|
2025
Q1 | $121M | Buy |
3,200,000
+863,204
| +37% | +$32.6M | 10.15% | 2 |
|
|
2024
Q4 | $191M | Buy |
2,336,796
+1,297,508
| +125% | +$106M | 11.31% | 2 |
|
|
2024
Q3 | $119M | Buy |
1,039,288
+286,048
| +38% | +$32.7M | 9.1% | 2 |
|
|
2024
Q2 | $56.9M | Buy |
753,240
+8,240
| +1% | +$622K | 4.39% | 6 |
|
|
2024
Q1 | $50.9M | Sell |
745,000
-257,407
| -26% | -$17.6M | 5.33% | 7 |
|
|
2023
Q4 | $63M | Sell |
1,002,407
-300,000
| -23% | -$18.8M | 6.97% | 4 |
|
|
2023
Q3 | $66.4M | Buy |
1,302,407
+2,407
| +0.2% | +$123K | 10.86% | 3 |
|
|
2023
Q2 | $64.9M | Buy |
1,300,000
+83,216
| +7% | +$4.16M | 8.93% | 4 |
|
|
2023
Q1 | $45.6M | Buy |
1,216,784
+513,343
| +73% | +$19.2M | 5.89% | 5 |
|
|
2022
Q4 | $33.7M | Buy |
703,441
+4,803
| +0.7% | +$230K | 5.17% | 5 |
|
|
2022
Q3 | $16.8M | Sell |
698,638
-25,143
| -3% | -$603K | 3.53% | 9 |
|
|
2022
Q2 | $15.7M | Buy |
723,781
+144,141
| +25% | +$3.14M | 4.02% | 9 |
|
|
2022
Q1 | $14M | Buy |
579,640
+368,157
| +174% | +$8.89M | 4.54% | 8 |
|
|
2021
Q4 | $5.03M | Buy |
+211,483
| New | +$5.03M | 2.69% | 14 |
|